King Albert II Cancer Institute: Difference between revisions
From Beacon
| Line 54: | Line 54: | ||
[https://www.institutroialbertdeux.be/en/cancer/pediatric-hematology-and-oncology Pediatric Hematology and Oncology] | [https://www.institutroialbertdeux.be/en/cancer/pediatric-hematology-and-oncology Pediatric Hematology and Oncology] | ||
[https://www.institutroialbertdeux.be/en/cancer/prostate-cancer Prostate cancer] | [https://www.institutroialbertdeux.be/en/cancer/prostate-cancer Prostate cancer] | ||
| Line 74: | Line 72: | ||
=== Research groups === | === Research groups === | ||
[https://www.institutroialbertdeux.be/en/cancer/phase-i-breakthrough-therapies Phase I - Breakthrough therapies] | |||
== [[Learning Resources]] == | == [[Learning Resources]] == | ||
Revision as of 19:15, 2 June 2023
Trials
Experts
Clinical groups
Cancer of the musculoskeletal system or sarcomas
Central nervous system (cns) tumors in children
Central nervous system cancer Cervical cancer
Pediatric Hematology and Oncology
Skin tumours – Melanoma Clinic
Research groups
Phase I - Breakthrough therapies
